Journal Logo

Most Popular Articles

Extended topoisomerase 1 inhibition through liposomal irinotecan results in improved efficacy over topotecan and irinotecan in models of small-cell lung cancer

Leonard, Shannon C.; Lee, Helen; Gaddy, Daniel F.; More

Anti-Cancer Drugs. 28(10):1086-1096, November 2017.

Survival outcomes of adjuvant chemotherapy with modified weekly nab-paclitaxel and carboplatin for completely resected nonsmall cell lung cancer: FAST-nab

Marushima, Hideki; Kimura, Hiroyuki; Miyazawa, Tomoyuki; More

Anti-Cancer Drugs. 31(2):177-182, February 2020.

Trastuzumab in combination with paclitaxel enhances antitumor activity by promoting apoptosis in human epidermal growth factor receptor 2-positive trastuzumab-resistant gastric cancer xenograft models

Shu, Sei; Yamashita-Kashima, Yoriko; Yanagisawa, Mieko; More

Anti-Cancer Drugs. 31(3):241-250, March 2020.

Trabectedin in advanced synovial sarcomas: a multicenter retrospective study from four European institutions and the Italian Rare Cancer Network

Sanfilippo, Roberta; Dileo, Palma; Blay, Jean-Yves; More

Anti-Cancer Drugs. 26(6):678-681, July 2015.

The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypes

Stathopoulos, George P.; Malamos, Nikolaos A.; Markopoulos, Christos; More

Anti-Cancer Drugs. 25(8):950-957, September 2014.

High-dose methotrexate in adults with osteosarcoma: a population pharmacokinetics study and validation of a new limited sampling strategy

Dupuis, Charlotte; Mercier, Cedric; Yang, Chenguang; More

Anti-Cancer Drugs. 19(3):267-273, March 2008.

DZ-2384 has a superior preclinical profile to taxanes for the treatment of triple-negative breast cancer and is synergistic with anti-CTLA-4 immunotherapy

Bernier, Cynthia; Soliman, Ahmed; Gravel, Michel; More

Anti-Cancer Drugs. 29(8):774-785, September 2018.

An 1H NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia

Cerchione, Claudio; Martinelli, Giovanni; Pedatella, Silvana; More

Anti-Cancer Drugs. 31(1):67-72, January 2020.

Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors

Grenader, Tal; Pavel, Marianne E.; Ruszniewski, Philippe B.; More

Anti-Cancer Drugs. 31(3):216-222, March 2020.

Palbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast cancer

Durairaj, Chandrasekar; Ruiz-Garcia, Ana; Gauthier, Eric R.; More

Anti-Cancer Drugs. 29(3):271-280, March 2018.

Venous thromboembolic events in patients with lung cancer treated with cisplatin-based versus carboplatin/nedaplatin-based chemotherapy

Mitani, Akihisa; Jo, Taisuke; Yasunaga, Hideo; More

Anti-Cancer Drugs. 29(6):560-564, July 2018.

Cyclin-dependent kinase inhibitors plus aromatase inhibitor in first-line treatment hormone-receptor–positive/HER2-negative advanced breast cancer women with or without visceral disease: time to turn page?

Nigro, Olga; Marrazzo, Cristina; Gallerani, Elisa; More

Anti-Cancer Drugs. 31(5):528-532, June 2020.

A case of heavily pretreated metastatic cardiac angiosarcoma treated successfully using eribulin

Inagaki, Chiaki; Shimoi, Tatsunori; Okuma, Hitomi; More

Anti-Cancer Drugs. 29(1):97-101, January 2018.

Complete response after rechallenge with trabectedin in a patient with previously responding high-grade undifferentiated sarcoma

Baldi, Giacomo G.; Di Donato, Samantha; Fargnoli, Rossana; More

Anti-Cancer Drugs. 27(9):908-913, October 2016.

Sodium meta-arsenite induces reactive oxygen species-dependent apoptosis, necrosis, and autophagy in both androgen-sensitive and androgen-insensitive prostate cancer cells

Kim, Yunlim; Jeong, In Gab; You, Dalsan; More

Anti-Cancer Drugs. 25(1):53-62, January 2014.

Generation of a humanized anti-glypican 3 antibody by CDR grafting and stability optimization

Nakano, Kiyotaka; Ishiguro, Takahiro; Konishi, Hiroko; More

Anti-Cancer Drugs. 21(10):907-916, November 2010.

Pharmacokinetics of pertuzumab administered concurrently with trastuzumab in Chinese patients with HER2-positive early breast cancer

Luo, Yang; Li, Wei; Jiang, Zefei; More

Anti-Cancer Drugs. 30(8):866-872, September 2019.

Show: